Atlas Trials

A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)

Clinical trial NCT01617187 · COMPLETED

Trial details

NCT number
NCT01617187
Sponsor
Organon and Co
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2012-12-04
Primary completion
2014-08-11
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.